PTC logo PTC +
PTC
+

PTC (PTC) Business News

Track PTC in real time with a live news feed covering PTC stock news, official press releases, company announcements, and an archive of historical PTC news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
8:00 AM | Thursday | Oct 22, 2026 GlobeNewsWire

Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse

News Thumbnail
8:00 AM | Thursday | Oct 22, 2026 GlobeNewsWire

Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse

News Thumbnail
8:30 AM | Wednesday | Oct 21, 2026 PRNewsWire

PTC Launches PTC Jetstream to Make Enterprise Collaboration a Connected Part of the Product Development Lifecycle

News Thumbnail
7:00 AM | Monday | Oct 19, 2026 PRNewsWire

PTC to Announce Fourth Fiscal Quarter and Full Year 2026 Results on Wednesday, November 4, 2026

News Thumbnail
8:00 AM | Thursday | Oct 15, 2026 PRNewsWire

PTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026

News Thumbnail
8:00 AM | Thursday | Oct 15, 2026 PRNewsWire

PTC Announces Servigistics Renewal with U.S. Air Force

News Thumbnail
12:00 PM | Monday | Oct 5, 2026 PRNewsWire

PTC SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES PTC INC.

News Thumbnail
5:25 AM | Monday | Oct 5, 2026 Business Wire

PTC Stock Alert: Halper Sadeh LLC is Investigating Whether PTC Inc. is Obtaining a Fair Price for its Shareholders

News Thumbnail
4:30 PM | Friday | Sep 25, 2026 PRNewsWire

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

News Thumbnail
4:30 PM | Monday | Sep 21, 2026 PRNewsWire

PTC Completes Acquisition of ST-920 Fabry Disease Gene Therapy

News Thumbnail
8:30 AM | Tuesday | Sep 15, 2026 PRNewsWire

PTC's Creo and Windchill Solutions Selected for Product Development across Fisica Applied Technologies

News Thumbnail

Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse

GlobeNewsWire

8:00 AM | Thursday | Oct 22, 2026

news photo
Loading...

In naturally aged mice treated from 80 weeks of age and followed until natural death, once-weekly PTC-2105 (25 mg/kg) significantly increased overall survival versus saline (log-rank p = 0.0142) “Speedy,” a PTC-2105-treated mouse now more than 167 weeks old, has outlived every saline-treated negative control in his study by more than 20% and remains active day and night New “Team Speedy” webpage, launching today at eossenolytix.com/team-speedy, invites the public to watch Speedy, predict how far he will go, and sign up for milestone alerts BERLIN and HOUSTON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Eos SENOLYTIX, Inc. (“Eos” or the “Company”) a biotechnology company developing mitochondria-targeted geropeptides to improve healthspan, today presented new preclinical survival, healthspan and mechanism-of-action data for its lead candidate, PTC-2105, in an Industry Keynote Address at the 17th World Congress on Targeting Mitochondria 2026 in Berlin.
The keynote, “Building on the Foundation of Four: Advancing Mitochondrial-Targeted Geropeptide Medicine,” delivered by Dr. Kevin Slawin, Founder and CEO of Eos SENOLYTIX, acknowledged the contribution of Dr. Hazel Szeto, who with Dr. Peter Schiller co-discovered the four amino acid peptide, SS-31, (“elamipretide”), the first FDA-approved therapeutic that directly targets mitochondria.

Read full article redirect
8:00 AM | Thursday | Oct 22, 2026

Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse

GlobeNewsWire

In naturally aged mice treated from 80 weeks of age and followed until natural death, once-weekly PTC-2105 (25 mg/kg) significantly increased overall survival versus saline (log-rank p = 0.0142) “Speedy,” a PTC-2105-treated mouse now more than 167 weeks old, has outlived every saline-treated negative control in his study by more than 20% and remains active day and night New “Team Speedy” webpage, launching today at eossenolytix.com/team-speedy, invites the public to watch Speedy, predict how far he will go, and sign up for milestone alerts BERLIN and HOUSTON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Eos SENOLYTIX, Inc. (“Eos” or the “Company”) a biotechnology company developing mitochondria-targeted geropeptides to improve healthspan, today presented new preclinical survival, healthspan and mechanism-of-action data for its lead candidate, PTC-2105, in an Industry Keynote Address at the... Read more

Read full article arrow
News Thumbnail
8:00 AM | Thursday | Oct 22, 2026

Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse

GlobeNewsWire

In naturally aged mice treated from 80 weeks of age and followed until natural death, once-weekly PTC-2105 (25 mg/kg) significantly increased overall survival versus saline (log-rank p = 0.0142) “Speedy,” a PTC-2105-treated mouse now more than 167 weeks old, has outlived every saline-treated negative control in his study by more than 20% and remains active day and night New “Team Speedy” webpage, launching today at eossenolytix.com/team-speedy, invites the public to watch Speedy, predict how far he will go, and sign up for milestone alerts BERLIN and HOUSTON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Eos SENOLYTIX, Inc. (“Eos” or the “Company”) a biotechnology company developing mitochondria-targeted geropeptides to improve healthspan, today presented new preclinical survival, healthspan and mechanism-of-action data for its lead candidate, PTC-2105, in an Industry Keynote Address at the... Read more

Read full article arrow
News Thumbnail
8:30 AM | Wednesday | Oct 21, 2026

PTC Launches PTC Jetstream to Make Enterprise Collaboration a Connected Part of the Product Development Lifecycle

PRNewsWire

Brings internal teams, suppliers, and partners into secure Rooms to review 2D and 3D product content in the browser Keeps comments, markups, versions, and decisions in context to accelerate reviews and reduce rework Leverages AI to turn complex discussions into clear and actionable next steps and Windchill connectivity to carry decisions into downstream execution BOSTON, Oct. 21, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the launch of its PTC Jetstream™ cloud and AI-native product collaboration solution to connect people, product information, and decisions – enabling product companies to move faster, catch issues earlier, and bring great products to market. As products become more complex, organizations need to bring expertise from across the business into the development process without slowing innovation, but reviews and discussions that shape a product are often... Read more

Read full article arrow
News Thumbnail
7:00 AM | Monday | Oct 19, 2026

PTC to Announce Fourth Fiscal Quarter and Full Year 2026 Results on Wednesday, November 4, 2026

PRNewsWire

BOSTON, Oct. 19, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) will release its fiscal 2026 fourth quarter and full year results on Wednesday, November 4th after the stock market closes. As previously announced on October 5th, 2026, PTC entered into a definitive agreement to be acquired by Schneider Electric.

Read full article arrow
News Thumbnail
8:00 AM | Thursday | Oct 15, 2026

PTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026

PRNewsWire

WARREN, N.J., Oct. 15, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its third quarter 2026 financial results and provide a business update on Thursday, Oct.
29, 2026, at 4:30 p.m.

Read full article arrow
News Thumbnail
8:00 AM | Thursday | Oct 15, 2026

PTC Announces Servigistics Renewal with U.S. Air Force

PRNewsWire

Optimizes service parts across complex global supply network Transforms planning productivity through exception-based management AI-powered intelligence built on deep service supply chain expertise and proven optimization science BOSTON, Oct. 15, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that the United States Air Force (USAF) has extended its use of PTC's Servigistics® service supply chain optimization solution as part of its Enterprise Supply Chain Analysis, Planning, and Execution (ESCAPE) program. The renewal extends a nearly decade-long relationship focused on modernizing the Air Force service supply chain and improving aircraft and system readiness.

Read full article arrow
News Thumbnail
12:00 PM | Monday | Oct 5, 2026

PTC SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES PTC INC.

PRNewsWire

PTC shareholders will receive just $205 per share in an all-cash transaction valuing PTC's equity at approximately $22.6 billion; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offers CLICK HERE TO JOIN MILWAUKEE, Oct. 5, 2026 /PRNewswire/ -- Ademi LLP is investigating whether the proposed acquisition of PTC (NASDAQ: PTC) by Schneider Electric, provides fair value to PTC's public shareholders and whether PTC's Board adequately protected shareholder interests in negotiating and approving the transaction. Are You a PTC Shareholder?

Read full article arrow
News Thumbnail
5:25 AM | Monday | Oct 5, 2026

PTC Stock Alert: Halper Sadeh LLC is Investigating Whether PTC Inc. is Obtaining a Fair Price for its Shareholders

Business Wire

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of PTC Inc. (NASDAQ: PTC) to Schneider Electric for $205.00 per share in cash. Halper Sadeh encourages PTC shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.
com. The investigation concerns whether PTC and its board of directors violated the federal secur.

Read full article arrow
News Thumbnail
4:30 PM | Friday | Sep 25, 2026

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PRNewsWire

WARREN, N.J., Sept. 25, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Sept.

Read full article arrow
News Thumbnail
4:30 PM | Monday | Sep 21, 2026

PTC Completes Acquisition of ST-920 Fabry Disease Gene Therapy

PRNewsWire

– Completion of BLA submission expected in Q4 2026 – WARREN, N.J., Sept. 21, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that it completed the previously announced agreement with Sangamo Therapeutics, Inc.
to acquire ST-920 – a BLA-stage, one-time administered AAV gene therapy for Fabry disease.

Read full article arrow
News Thumbnail
8:30 AM | Tuesday | Sep 15, 2026

PTC's Creo and Windchill Solutions Selected for Product Development across Fisica Applied Technologies

PRNewsWire

Standardizes on Creo CAD and Windchill PLM across multiple business units and locations Supports design consistency, configuration control, and traceability for complex defense programs Supports both near‑term operational needs and long‑term growth BOSTON, Sept. 15, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that Fisica Applied Technologies, Inc., a leading defense products manufacturer of airborne and ground-based antennas; electromagnetic systems and simulators; and ruggedized batteries, has selected the PTC Creo® computer-aided design (CAD) and Windchill® product lifecycle management (PLM) solutions for product design and development across its engineering environment.

Read full article arrow
News Thumbnail